Predilife

medical devices

About

Predilife is a French company founded in 2004 that specializes in predictive medicine. The company develops and markets predictive tests to assess individual risks of serious diseases, with a particular focus on breast cancer. By combining proven medical techniques, such as imaging and genetic data, with artificial intelligence and big data, Predilife personalizes disease risk assessments to enable early detection and prevention. The company's flagship product, MammoRisk®, provides personalized risk scores for breast cancer by integrating multiple risk factors. Predilife also offers comprehensive predictive check-ups that anticipate disease risks, allowing for early intervention. Their products have received medical device certification, ensuring compliance with regulatory standards. Predilife collaborates with leading cancer research centers and markets its products both in France and internationally, aiming to make predictive medicine accessible to all.

Technologies

MailJet Postmark Gmail Google Apps MailChimp SPF Google Analytics Google Dynamic Remarketing DoubleClick Conversion YouTube Mobile Friendly Shutterstock Vimeo Hotjar Nginx Cedexis Radar Google Tag Manager WordPress.org Hubspot Adobe Media Optimizer DoubleClick

Keywords

breast cancer risk assesment calcul de risque du cancer du sein statistics data mining prediction de pathologies cancer du sein medecine predictive medecine 6p medecine preventive bilan de sante predictif intelligence artificielle maladies cardiovasculaires cancer de la prostate cancer colorectal melanome cancer du poumon drh ressources humaines marque employeur rse qvt sante au travail sante en entreprise medical equipment manufacturing b2b mammorisk plateforme de télésanté risque maladie grave évaluation du risque de cancer b2c

Location

114 Rue Edouard Vaillant, Villejuif, Ile-de-France, France, 94800

Related Companies

Companies in the same industry